AVADEL PHARMACEUTICALS (AVDL) Stock Analyst Earnings Estimates
NASDAQ:AVDL - Nasdaq - IE00BDGMC594 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 27.963M | 172.15M 515.63% | 257.05M 49.32% | 346.91M 34.96% | 465.99M 34.33% | 470.19M 0.90% | 546.88M 16.31% | 428.4M -21.66% | ||
| EBITDA YoY % growth | -84.784M -121.38% | -93.723M -10.54% | -136.083M -45.20% | -17.003M 87.51% | 82.278M 583.89% | 187.13M 127.44% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -85.599M -114.06% | -95.216M -11.23% | -137.849M -44.78% | -42.654M 69.06% | 32.715M 176.70% | 118.57M 262.43% | 204.1M 72.13% | 223.72M 9.61% | 254.9M 13.94% | 198.9M -21.97% | |
| Operating Margin | N/A | N/A | -492.97% | -24.78% | 12.73% | 34.18% | 43.80% | 47.58% | 46.61% | 46.43% | |
| EPS YoY % growth | -1.32 -135.71% | -2.25 -70.45% | -2.01 10.67% | -0.51 74.60% | 0.09 116.93% | 0.79 810.96% | 2.44 210.37% | 2.81 15.03% | 2.44 -13.25% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 85.76% | -0.06 79.15% | 0.00 99.69% | 0.05 251.54% | 0.12 383.23% | 0.03 148.92% | 0.11 25,681.40% | 0.14 214.11% | 0.22 91.79% |
| Revenue Q2Q % growth | 51.058M 162.47% | 54.161M 99.28% | 61.115M 47.25% | 67.544M 35.02% | 74.444M 45.80% | 67.422M 24.48% | 78.03M 27.68% | 82.722M 22.47% | 93.636M 25.78% |
| EBITDA Q2Q % growth | -612K 97.35% | 6.722M 126.37% | 15.096M 228.33% | 24.052M 1,326.57% | 34.405M 5,721.73% | 7.242M 7.74% | 17.136M 13.51% | 21.522M -10.52% | 31.62M -8.09% |
| EBIT Q2Q % growth | -2.399M 90.36% | -1.658M 93.63% | 4.819M 137.82% | 10.844M 3,416.21% | 19.552M 914.95% | 5.61M 438.46% | 15.402M 219.61% | 19.788M 82.48% | 29.988M 53.38% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.03 92.68% | -0.06 | 0.03 | 46.72% |
| Q2 2024 Q2Q % growth | -0.14 83.13% | -0.16 | 0.02 | 11.79% |
| Q1 2024 Q2Q % growth | -0.30 37.50% | -0.21 | -0.09 | -41.55% |
| Q4 2023 Q2Q % growth | -0.29 36.96% | -0.26 | -0.03 | -9.63% |
| Q3 2023 Q2Q % growth | -0.41 -24.24% | -0.38 | -0.03 | -7.98% |
| Q2 2023 Q2Q % growth | -0.83 17.82% | -0.39 | -0.44 | -111.75% |
| Q1 2023 Q2Q % growth | -0.48 -6.67% | -0.38 | -0.10 | -24.86% |
| Q4 2022 Q2Q % growth | -0.46 -21.05% | -0.28 | -0.18 | -66.41% |
| Q3 2022 Q2Q % growth | -0.33 13.16% | -0.26 | -0.07 | -27.71% |
| Q2 2022 Q2Q % growth | -1.01 -206.06% | -0.42 | -0.59 | -141.71% |
| Q1 2022 Q2Q % growth | -0.45 -95.65% | -0.44 | -0.01 | -2.01% |
| Q4 2021 Q2Q % growth | -0.38 -100.00% | -0.42 | 0.04 | 10.01% |
| Q3 2021 Q2Q % growth | -0.38 -90.00% | -0.39 | 0.01 | 3.23% |
| Q2 2021 Q2Q % growth | -0.33 -120.00% | -0.32 | -0.01 | -2.89% |
| Q1 2021 Q2Q % growth | -0.23 -1,050.00% | -0.32 | 0.09 | 29.04% |
| Q4 2020 Q2Q % growth | -0.19 -171.43% | -0.28 | 0.09 | 31.29% |
| Q3 2020 Q2Q % growth | -0.20 16.67% | -0.26 | 0.06 | 21.96% |
| Q2 2020 Q2Q % growth | -0.15 34.78% | -0.10 | -0.05 | -52.79% |
| Q1 2020 Q2Q % growth | -0.02 94.29% | -0.24 | 0.22 | 91.76% |
| Q4 2019 Q2Q % growth | -0.07 | -0.25 | 0.18 | 71.99% |
| Q3 2019 Q2Q % growth | -0.24 | -0.28 | 0.04 | 12.85% |
| Q2 2019 Q2Q % growth | -0.23 | -0.30 | 0.07 | 22.24% |
| Q1 2019 Q2Q % growth | -0.35 | -0.50 | 0.15 | 29.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 50.025M 613.22% | 49.579M | 446K | 0.90% |
| Q2 2024 Q2Q % growth | 41.504M 2,674.33% | 38.285M | 3.219M | 8.41% |
| Q1 2024 Q2Q % growth | 27.178M | 26.416M | 762K | 2.88% |
| Q4 2023 Q2Q % growth | 19.453M | 18.574M | 879K | 4.73% |
| Q3 2023 Q2Q % growth | 7.014M | 5.19M | 1.824M | 35.14% |
| Q2 2023 Q2Q % growth | 1.496M | 643.763K | 852.237K | 132.38% |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 10.091M -42.51% | 7.516M | 2.575M | 34.26% |
| Q1 2020 Q2Q % growth | 12.243M -25.52% | 10.353M | 1.89M | 18.26% |
| Q4 2019 Q2Q % growth | 10.995M | 9.316M | 1.679M | 18.02% |
| Q3 2019 Q2Q % growth | 14.229M | 10.455M | 3.774M | 36.10% |
| Q2 2019 Q2Q % growth | 17.554M | 10.71M | 6.844M | 63.90% |
| Q1 2019 Q2Q % growth | 16.437M | 14.153M | 2.284M | 16.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -30.18% | -223.55% | -11.96% | -9.48% |
| Revenue | -5.15% | -6.53% | -1.32% | -2.78% |